Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2016, Article ID 1863508, 7 pages
http://dx.doi.org/10.1155/2016/1863508
Research Article

Event-Related Potentials in Parkinson’s Disease Patients with Visual Hallucination

1Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
2Department of Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
3Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

Received 22 September 2016; Accepted 9 November 2016

Academic Editor: Jan Aasly

Copyright © 2016 Yang-Pei Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Williams and A. J. Lees, “Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study,” Lancet Neurology, vol. 4, no. 10, pp. 605–610, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Levy, M.-X. Tang, E. D. Louis et al., “The association of incident dementia with mortality in PD,” Neurology, vol. 59, no. 11, pp. 1708–1713, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Ibarretxe-Bilbao, B. Ramirez-Ruiz, C. Junque et al., “Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 81, no. 6, pp. 650–657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Fénelon, C. G. Goetz, and A. Karenberg, “Hallucinations in Parkinson disease in the prelevodopa era,” Neurology, vol. 66, no. 1, pp. 93–98, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Aarsland, K. Andersen, J. P. Larsen, A. Lolk, and P. Kragh-Sørensen, “Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study,” Archives of Neurology, vol. 60, no. 3, pp. 387–392, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Aarsland, K. Andersen, J. P. Larsen et al., “The rate of cognitive decline in Parkinson disease,” Archives of Neurology, vol. 61, no. 12, pp. 1906–1911, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. N. J. Diederich, C. G. Goetz, and G. T. Stebbins, “Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model,” Movement Disorders, vol. 20, no. 2, pp. 130–140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Barnes, L. Boubert, J. Harris, A. Lee, and A. S. David, “Reality monitoring and visual hallucinations in Parkinson's disease,” Neuropsychologia, vol. 41, no. 5, pp. 565–574, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Smulders, M. van Nimwegen, M. Munneke, B. R. Bloem, R. P. C. Kessels, and R. A. J. Esselink, “Involvement of specific executive functions in mobility in Parkinson's disease,” Parkinsonism & Related Disorders, vol. 19, no. 1, pp. 126–128, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Pagonabarraga and J. Kulisevsky, “Cognitive impairment and dementia in Parkinson's disease,” Neurobiology of Disease, vol. 46, no. 3, pp. 590–596, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Wu, L. Chen, Y. Zheng et al., “Cognitive impairment is common in Parkinson's disease without dementia in the early and middle stages in a Han Chinese cohort,” Parkinsonism & Related Disorders, vol. 18, no. 2, pp. 161–165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Y. Uc, M. P. McDermott, K. S. Marder et al., “Incidence of and risk factors for cognitive impairment in an early parkinson disease clinical trial cohort,” Neurology, vol. 73, no. 18, pp. 1469–1477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Ramirez-Ruiz, C. Junque, M.-J. Marti, F. Valldeoriola, and E. Tolosa, “Cognitive changes in Parkinson's disease patients with visual hallucinations,” Dementia and Geriatric Cognitive Disorders, vol. 23, no. 5, pp. 281–288, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Reginold, M. J. Armstrong, S. Duff-Canning et al., “The pill questionnaire in a nondemented Parkinson's disease population,” Movement Disorders, vol. 27, no. 10, pp. 1308–1311, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Ramírez-Ruiz, C. Junqué, M.-J. Martí, F. Valldeoriola, and E. Toloso, “Neuropsychological deficits in Parkinson's disease patients with visual hallucinations,” Movement Disorders, vol. 21, no. 9, pp. 1483–1487, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Gibson, P. G. Mottram, D. J. Burn et al., “Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study,” International Journal of Geriatric Psychiatry, vol. 28, no. 6, pp. 626–631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Grossi, L. Trojano, M. T. Pellecchia, M. Amboni, N. A. Fragassi, and P. Barone, “Frontal dysfunction contributes to the genesis of hallucination in non-demented Parkinsonian patients,” International Journal of Geriatric Psychiatry, vol. 20, no. 7, pp. 668–673, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Llebaria, J. Pagonabarraga, M. Martínez-Corral et al., “Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease,” Movement Disorders, vol. 25, no. 16, pp. 2785–2791, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. G. Goetz, C. L. Vaughan, J. G. Goldman, and G. T. Stebbins, “I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging,” Movement Disorders, vol. 29, no. 1, pp. 115–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Yamasaki, S. Horie, H. Muranaka, Y. Kaseda, Y. Mimori, and S. Tobimatsu, “Relevance of in vivo neurophysiological biomarkers for mild cognitive impairment and Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 31, supplement 3, pp. S137–S154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. C.-L. Lai, R.-T. Lin, L.-M. Liou, Y.-H. Yang, and C.-K. Liu, “The role of cognitive event-related potentials in executive dysfunction,” Kaohsiung Journal of Medical Sciences, vol. 29, no. 12, pp. 680–686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-L. Lai, R.-T. Lin, L.-M. Liou, and C.-K. Liu, “The role of event-related potentials in cognitive decline in Alzheimer's disease,” Clinical Neurophysiology, vol. 121, no. 2, pp. 194–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Polich, J. E. Alexander, L. O. Bauer et al., “P300 topography of Amplitude/Latency correlations,” Brain Topography, vol. 9, no. 4, pp. 275–282, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Polich and T. Bondurant, “P300 sequence effects, probability, and interstimulus interval,” Physiology & Behavior, vol. 61, no. 6, pp. 843–849, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Wang, Y. Wang, D. Wang, L. Cui, S. Tian, and Y. Zhang, “Cognitive impairment in Parkinson's disease revealed by event-related potential N270,” Journal of the Neurological Sciences, vol. 194, no. 1, pp. 49–53, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Prabhakar, P. Syal, and T. Srivastava, “P300 in newly diagnosed non-dementing Parkinson's disease: effect of dopaminergic drugs,” Neurology India, vol. 48, no. 3, pp. 239–242, 2000. View at Google Scholar · View at Scopus
  27. H. Tanaka, T. Koenig, R. D. Pascual-Marqui, K. Hirata, K. Kochi, and D. Lehmann, “Event-related potential and EEG measures in Parkinson's disease without and with dementia,” Dementia and Geriatric Cognitive Disorders, vol. 11, no. 1, pp. 39–45, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Aotsuka, S. J. Weate, M. E. Drake Jr., and G. W. Paulson, “Event-related potentials in Parkinson's disease,” Electromyography and Clinical Neurophysiology, vol. 36, no. 4, pp. 215–220, 1996. View at Google Scholar · View at Scopus
  29. K. Toda, H. Tachibana, M. Sugita, and K. Konishi, “P300 and reaction time in Parkinson's disease,” Journal of Geriatric Psychiatry and Neurology, vol. 6, no. 3, pp. 131–136, 1993. View at Publisher · View at Google Scholar · View at Scopus
  30. D. O'Mahony, M. Rowan, J. Feely, D. O'Neill, J. B. Walsh, and D. Coakley, “Parkinson's dementia and Alzheimer's dementia: an evoked potential comparison,” Gerontology, vol. 39, no. 4, pp. 228–240, 1993. View at Google Scholar · View at Scopus
  31. S. Pang, J. C. Borod, A. Hernandez et al., “The auditory P300 correlates with specific cognitive deficits in Parkinson's disease,” Journal of Neural Transmission-Parkinson's Disease and Dementia Section, vol. 2, no. 4, pp. 249–264, 1990. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Kurita, M. Murakami, S. Takagi, M. Matsushima, and M. Suzuki, “Visual hallucinations and altered visual information processing in Parkinson disease and dementia with lewy bodies,” Movement Disorders, vol. 25, no. 2, pp. 167–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Manganelli, C. Vitale, G. Santangelo et al., “Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease,” Brain, vol. 132, no. 9, pp. 2350–2355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Sanchez-Castaneda, R. Rene, B. Ramirez-Ruiz et al., “Frontal and associative visual areas related to visual hallucinations in dementia with lewy bodies and Parkinson's disease with dementia,” Movement Disorders, vol. 25, no. 5, pp. 615–622, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. H. H. Fernandez and K. L. Lapane, “Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease,” Medical Science Monitor, vol. 8, no. 4, pp. CR241–CR246, 2002. View at Google Scholar · View at Scopus
  36. H. H. Fernandez, K. L. Lapane, B. R. Ott, and J. H. Friedman, “Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology,” Movement Disorders, vol. 15, no. 3, pp. 490–496, 2000. View at Publisher · View at Google Scholar
  37. V. T. Nasman and P. J. Dorio, “Reduced P3b category response in prefrontal patients,” International Journal of Psychophysiology, vol. 14, no. 1, pp. 61–74, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Kimura, A. Ohnuma, H. Seki, S.-I. Saso, and K. Kogure, “Cognitive impairment in Parkinson's disease assessed by visuomotor performance system and P300 potential,” The Tohoku Journal of Experimental Medicine, vol. 161, pp. 155–165, 1990. View at Google Scholar · View at Scopus
  39. J. Janzen, D. Van'T Ent, A. W. Lemstra, H. W. Berendse, F. Barkhof, and E. M. J. Foncke, “The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study,” Journal of Neurology, vol. 259, no. 1, pp. 147–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Thomas, D. Iacono, L. Bonanni, G. D'Andreamatteo, and M. Onofrj, “Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months,” Clinical Neuropharmacology, vol. 24, no. 1, pp. 31–42, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Onofrj, A. Thomas, A. L. Luciano et al., “Donepezil versus vitamin E in Alzheimer's Disease part 2: mild versus moderate-severe Alzheimer's Disease,” Clinical Neuropharmacology, vol. 25, no. 4, pp. 207–215, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. A. J. Muller, J. M. Shine, G. M. Halliday, and S. J. G. Lewis, “Visual hallucinations in Parkinson's disease: theoretical models,” Movement Disorders, vol. 29, no. 13, pp. 1591–1598, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. J. M. Shine, C. O'Callaghan, G. M. Halliday, and S. J. G. Lewis, “Tricks of the mind: visual hallucinations as disorders of attention,” Progress in Neurobiology, vol. 116, pp. 58–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. A.-Q. Rana, A. Kabir, O. Dogu, A. Patel, and S. Khondker, “Prevalence of blepharospasm and apraxia of eyelid opening in patients with parkinsonism, cervical dystonia and essential tremor,” European Neurology, vol. 68, no. 5, pp. 318–321, 2012. View at Publisher · View at Google Scholar · View at Scopus